Status and phase
Conditions
Treatments
About
Multicenter prospective phase II study evaluating regorafenib in older patients with metastatic colorectal cancer
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
43 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal